Able Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Buy
482
+169
+54% +$173K 0.13% 76
2026
Q1
$255K Buy
313
+57
+22% +$57.8K 0.07% 105
2025
Q4
$236K Buy
+256
New +$245K 0.07% 100
2024
Q1
Sell
-129
Closed -$75.5K 360
2023
Q4
$75.5K Buy
+129
New +$75.3K 0.07% 110

Other funds holding LLY

Able Wealth Management's LLY Position: Q2 2026 in Review

Able Wealth Management increased its Eli Lilly (LLY) stake by 54% in Q2 2026, buying an estimated $173K and bringing the position to 482 shares worth $569K. The position accounts for 0.13% of the portfolio, ranked #76.

Able Wealth Management first reported a position in LLY in Q4 2023 and has held it in 4 quarters since. 4,627 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Able Wealth Management held 482 shares of Eli Lilly worth $569K as of Q2 2026.
  • Able Wealth Management bought 169 Eli Lilly shares in Q2 2026, an estimated $173K.
  • Eli Lilly made up 0.13% of Able Wealth Management's portfolio in Q2 2026, its #76 holding.
  • Able Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 4 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Able Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.